Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data

INTRODUCTION: The risk for development of a second primary lung cancer (SPLC) after treatment of an initial primary lung cancer (IPLC) is around 1% to 2% per patient per year. The present screening and surveillance guidelines do not adequately address this particular patient population. METHODS: We...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Thorac Oncol
Egile Nagusiak: Thakur, Manish K., Ruterbusch, Julie J., Schwartz, Ann G., Gadgeel, Shirish M., Beebe-Dimmer, Jennifer L., Wozniak, Antoinette J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6108174/
https://ncbi.nlm.nih.gov/pubmed/28989038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2017.09.1964
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak